Recap: VistaGen Therapeutics Q3 Earnings


VistaGen Therapeutics VTGN reported its Q3 earnings results on Thursday, February 10, 2022 at 05:00 PM.

Here's what investors need to know about the announcement.


VistaGen Therapeutics beat estimated earnings by 28.57%, reporting an EPS of $-0.05 versus an estimate of $-0.07.

Revenue was up $44.30 thousand from the same period last year.

Past Earnings Performance

Last quarter the company missed on EPS by $0.01, which was followed by a 4.0% increase in the share price the next day.

Here's a look at VistaGen Therapeutics's past performance:


Quarter Q2 2022 Q1 2022 Q4 2021 Q3 2021
EPS Estimate -0.06 -0.05 -0.05 -0.05
EPS Actual -0.07 -0.04 -0.30 -0.07
Revenue Estimate 260.00K 380.00K 230.00K 210.00K
Revenue Actual 358.00K 354.10K 441.90K 313.60K

To track all upcoming earnings announcements, click to use Benzinga Earnings Calendar.

This article was generated by Benzinga's automated content engine and reviewed by an editor.

Market News and Data brought to you by Benzinga APIs
Actual EPS
EPS Surprise
Actual Rev
Rev Surprise
Posted In: EarningsBZI-Recaps
Benzinga simplifies the market for smarter investing

Trade confidently with insights and alerts from analyst ratings, free reports and breaking news that affects the stocks you care about.

Join Now: Free!